Advanced Lipid Assessment Solution—VAP lipid subfraction detection

The Vertical Auto Profile (VAP) Lipid Subfraction Test is a patented, comprehensive advanced lipoprotein analysis developed by VAP Diagnostics Laboratory (formerly Atherotech, established in 1995). The test provides an expanded lipid profile far beyond traditional lipid panels, enabling enhanced cardiovascular risk detection, earlier intervention, and personalized treatment strategies. In 2016, the VAP platform was acquired and further developed by MedicalSystem Biotechnology Co., Ltd. (SZSE: 300439). The VAP lipid subfraction test is a comprehensive advanced lipoprotein analysis that includes 13 lipid parameters: low-density lipoprotein particle number (LDL-P), remnant lipoproteins (RLP), low-density lipoprotein density pattern (LDL Density Pattern), low-density lipoprotein subfractions (LDL4+3+2+1), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), very low-density lipoprotein 3 (VLDL3), high-density lipoprotein 2 (HDL2), high-density lipoprotein 3 (HDL3), non-high-density lipoprotein cholesterol (Non-HDL-C), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C).